News

Revolutionizing Emergency Care: Velico’s Plasma System Adoption

Revolutionizing Emergency Care: Velico’s Plasma System Adoption

Introducing a Pioneering Partnership in Blood Transfusion

In a remarkable collaboration, Velico Inc. has joined forces with South Texas Blood & Tissue (STB&T), a leading nonprofit organization recognized for its contributions to blood supply and transfusion practices. This partnership marks a significant milestone, as STB&T has become the first civilian blood center in the United States to implement Velico’s cutting-edge FrontlineODP™ Spray Dried Plasma System, enhancing the capabilities of blood product supplies.

Understanding the FrontlineODP™ Spray Dried Plasma System

The FrontlineODP™ System is designed to generate on-demand spray dried plasma. This innovative technology transforms conventional methods of plasma storage and delivery, particularly in scenarios where traditional frozen plasma is hard to access. The powdered plasma produced by Velico can be stored at ambient temperatures, and, when needed, can be quickly reconstituted for transfusion within just 2 ½ minutes, making it an invaluable resource in emergency situations.

Why This Matters

The ability to produce stable, easily transportable plasma products revolutionizes emergency care. It addresses critical needs such as:

  • Assisting First Responders: Ground and air ambulances benefit significantly from instant access to life-saving plasma.
  • Supporting Rural Hospitals: These medical facilities often lack sufficient plasma supplies, and this system can bridge that gap.
  • Military Applications: The system is particularly beneficial for military operations where access to blood products is limited.
  • Rapid Response in Mass Casualty Events: Stockpiled powdered plasma can be deployed swiftly during crises.

Insights from Industry Leaders

Richard Meehan, President and CEO of Velico Medical, expressed optimism regarding the partnership with STB&T. He underscored that this collaboration is likely to yield essential insights that will refine best practices in blood transfusion. As Meehan noted, “The FrontlineODP™ system presents an opportunity to save numerous lives on an annual basis, particularly in emergency medical contexts.”

Community Impact

Audra Taylor, Vice President of Blood Operations at STB&T, also shared her enthusiasm: “By participating in this program, we aim to enhance the standards of blood administration. The introduction of FrontlineODP™ will allow us to provide crucial plasma to emergency services, which currently face challenges in accessing plasma products.”

The Future of Blood Supply Management

The FrontlineODP™ is under investigation and has yet to receive FDA approval for clinical use. However, early access for centers like STB&T facilitates a vital evaluation phase, ensuring efficient commissioning and operational performance in real-world settings. This systematic approach will contribute to the program's readiness for future commercialization.

About South Texas Blood & Tissue

As the largest blood supplier in its region, South Texas Blood & Tissue operates with the mission to provide critical blood, plasma, and platelets to numerous hospitals across South Texas. With over 50 years of dedicated service, they are integral to their communities, supporting both blood donation and tissue recovery efforts.

Broader Implications for Healthcare

Velico, situated in Beverly, Massachusetts, has dedicated itself to developing innovative technologies that combat preventable deaths due to bleeding. With a strong focus on building partnerships across both civilian and military sectors, Velico is positioned at the forefront of medical advancements that promise to improve trauma care across various contexts.

The Road Ahead for Velico and STB&T

As the use of the FrontlineODP™ system expands, both companies and healthcare providers nationwide will closely monitor its progress. The collaboration sets a promising outlook for enhancing emergency medical services, stemming from innovations that prioritize rapid and effective medical responses in critical situations.

Frequently Asked Questions

What is the FrontlineODP™ Spray Dried Plasma System?

The FrontlineODP™ system produces powdered plasma that can be reconstituted for transfusion, providing an accessible and efficient solution for emergency care.

How will this system benefit rural hospitals?

Rural hospitals often face challenges in maintaining sufficient plasma supplies. The FrontlineODP™ system enables these facilities to deliver vital plasma products when needed.

What is the expected timeline for FDA approval?

The system is currently under investigation, and a specific timeline for FDA approval has yet to be announced.

Who are the key partners in this initiative?

Centrally, the partnership involves Velico Inc. and South Texas Blood & Tissue, along with various medical professionals and emergency services stakeholders.

What is the main goal of Velico?

Velico aims to eliminate preventable deaths due to bleeding through innovative medical technologies and partnerships with healthcare providers.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 21

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 10

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 20

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 14

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 22

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 18

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding F5 Inc.'s Stock Performance and Valuation

Updated Category News Views 180

Analyzing F5 Inc.'s Stock Metrics In today's market, F5 Inc. (NASDAQ: FFIV) is trading at $315.70 after experiencing a slight decrease of 0.48%. Interestingly, over the past month, the company has seen its stock rise by 5.50%, and in the last year, it has impressively increased by 58.08%. This growth prompts shareholders to contemplate whether the stock's current...

Continue Reading
Jeffs’ Brands Enters Strategic Agreement for Security Tech Expansion

Updated Category News Views 127

Exploring New Horizons: Jeffs’ Brands' Non-Binding MOU The 3D, AI-Powered Technology Screens 25,000 People Per Hour—Without Stopping Them In an exciting development for Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (NASDAQ: JFBR, JFBRW), a leading data-driven e-commerce firm leveraging the Amazon Marketplace, the company has announced its wholly owned...

Continue Reading
Essential Tips for Managing Chronic Back Pain and Health

Updated Category News Views 94

Understanding Pain Awareness Month September signals National Pain Awareness Month, a significant time to shed light on the challenges and treatment options for managing pain. Chronic pain impacts millions worldwide, deeply affecting day-to-day life. In particular, lower back pain is alarming, affecting over 619 million people globally according to recent statistics....

Continue Reading
Nerivio® REN Wearable Receives Approval in China for Migraine Relief

Updated Category News Views 336

Pier 88 Health and Theranica Revolutionize Migraine Treatment Pier 88 Health, a pioneer in digital health, and Theranica have announced a significant advancement in migraine treatment. Their groundbreaking product, the Nerivio® REN wearable, is now approved by China's National Medical Products Administration (NMPA), marking a pivotal moment for those suffering from this...

Continue Reading
Join the Excitement of CARNIVALE 2026 at Grace Cathedral

Updated Category News Views 198

Experience the Vibrant CARNIVALE 2026 Celebration Grace Cathedral, the cherished Episcopal landmark, is proud to announce the return of its spectacular Mardi Gras gala, CARNIVALE 2026. This exciting event is scheduled for February 13, 2026, promising to be a grand festive evening filled with joy and celebration. The Theme: Noite de Carnaval This year's theme, Noite de...

Continue Reading